This is a randomized controlled trial comparing the outcomes of treatment and non-treatment of elevated blood pressures in early pregnancy.
Patients will be randomized to treatment of elevated blood pressures (120 or greater systolic OR 80 or greater diastolic) versus non-treatment. After randomization to treatment, patient's will be treated with either nifedipine or labetalol (both medications that are standard of care for treatment of elevated blood pressure during pregnancy). The purpose of this study is two-fold: 1) Determine if treatment of elevated blood pressures (120 or greater systolic OR 80 or greater diastolic) versus non-treatment improves maternal and fetal outcomes and 2) determine if ICG directed treatment is optimal as ICG will not be used to determine treatment medication (this will be done by secondary analysis after conclusion of the study).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2
Standard of care for treatment of elevated blood pressure during pregnancy
Standard of care for treatment of elevated blood pressure during pregnancy
Marshall Obstetrics and Gynecology
Huntington, West Virginia, United States
Treatment of elevated blood pressures
Patient age
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
BMI
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
delivery weeks
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
systemic vascular resistance
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
heart rate
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
blood pressure
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
gravidity
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
parity
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
abortions
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Treatment of elevated blood pressures
gestational hypertension
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
inhouse days
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
preeclampsia
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
birth weight percentile
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
Apgar 1 min
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
Apgar 5 min
Time frame: through study completion, an average of 1 year
Treatment of elevated blood pressures
NICU days
Time frame: through study completion, an average of 1 year
ICG directed treatment
Compare cardiac output
Time frame: through study completion, an average of 1 year
ICG directed treatment
mean arterial pressure
Time frame: through study completion, an average of 1 year
ICG directed treatment
systemic vascular resistance among groups treated with nifedipine, labetalol, and the control group
Time frame: through study completion, an average of 1 year